UB Paderborn / Katalog / Suche / in CDI

Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis

JCI insight, 2022-02, Vol.7 (4)

2022

Volltextzugriff (PDF)

Metabolomics Approach to Reveal the Effects of Ocean Acidification on the Toxicity of Harmful Microalgae: A Review of the Literature

AppliedChem, 2023-03, Vol.3 (1), p.169-195

2023

Volltextzugriff (PDF)

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

Blood cancer journal (New York), 2020-10, Vol.10 (10), p.102-102, Article 102

2020

Volltextzugriff (PDF)

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334

2013

Volltextzugriff (PDF)

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

The New England journal of medicine, 2022-04, Vol.386 (15), p.1397-1408

2022

Volltextzugriff (PDF)

MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials

Blood, 2023-02, Vol.141 (6), p.579-591

2023

Volltextzugriff (PDF)

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

The lancet oncology, 2015-02, Vol.16 (2), p.141-151

2015

Volltextzugriff (PDF)

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR

Clinical lymphoma, myeloma and leukemia, 2020-08, Vol.20 (8), p.509-518

2020

Volltextzugriff (PDF)

Macrophages Promote Progression of Spasmolytic Polypeptide-Expressing Metaplasia After Acute Loss of Parietal Cells

Gastroenterology (New York, N.Y. 1943), 2014-06, Vol.146 (7), p.1727-1738.e8

2014

Volltextzugriff (PDF)

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti–IL-6) in multiple myeloma

Blood, 2014-06, Vol.123 (26), p.4136-4142

2014

Volltextzugriff (PDF)

Autonomic function tests: some clinical applications

Journal of clinical neurology (Seoul, Korea), 2013-01, Vol.9 (1), p.1-8

2013

Volltextzugriff (PDF)

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Annals of hematology, 2019-09, Vol.98 (9), p.2139-2150

2019

Volltextzugriff (PDF)

Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk

Journal of hematology and oncology, 2020-08, Vol.13 (1), p.115-115, Article 115

2020

Volltextzugriff (PDF)

IgA vasculitis presenting as recurrent hemopericardium

Rheumatology (Oxford, England), 2021-02, Vol.60 (2), p.993-994

2021

Volltextzugriff (PDF)

Improving Self-Confidence of Military Medical Providers With Joint Procedure Simulation: A Pilot Study

Military medicine, 2023-01, Vol.188 (1-2), p.e382-e387

2023

Volltextzugriff (PDF)

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

The New England journal of medicine, 2017-11, Vol.377 (18), p.1723-1732

2017

Volltextzugriff (PDF)

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2023-06, Vol.41 (16), p.2869-2876

2023

Volltextzugriff (PDF)

Precision and accuracy of single-molecule FRET measurements-a multi-laboratory benchmark study

Nature methods, 2018-09, Vol.15 (9), p.669

2018

Volltextzugriff (PDF)

CD36 mediates albumin transcytosis by dermal but not lung microvascular endothelial cells: role in fatty acid delivery

American journal of physiology. Lung cellular and molecular physiology, 2019-05, Vol.316 (5), p.L740-L750

2019

Volltextzugriff (PDF)

Subpopulation Treatment Effect Pattern Plot (STEPP) Methods with R and Stata

Journal of Data Science, 2023-01, Vol.21 (1), p.106-126

2023

Volltextzugriff (PDF)

Complete Myeloperoxidase Deficiency: Beware the “False-Positive” Dihydrorhodamine Oxidation

The Journal of pediatrics, 2016-09, Vol.176, p.204-206

2016

Volltextzugriff (PDF)

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Antiviral research, 2019-08, Vol.168, p.9-17

2019

Volltextzugriff (PDF)

Experimental study on incremental sheet forming of magnesium alloy AZ31 with hot air heating

Procedia manufacturing, 2018, Vol.15, p.1192-1199

2018

Volltextzugriff (PDF)

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

Annals of hematology, 2021-04, Vol.100 (4), p.1065-1077

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis

Metabolomics Approach to Reveal the Effects of Ocean Acidification on the Toxicity of Harmful Microalgae: A Review of the Literature

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR

Macrophages Promote Progression of Spasmolytic Polypeptide-Expressing Metaplasia After Acute Loss of Parietal Cells

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti–IL-6) in multiple myeloma

Autonomic function tests: some clinical applications

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk

IgA vasculitis presenting as recurrent hemopericardium

Improving Self-Confidence of Military Medical Providers With Joint Procedure Simulation: A Pilot Study

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Precision and accuracy of single-molecule FRET measurements-a multi-laboratory benchmark study

CD36 mediates albumin transcytosis by dermal but not lung microvascular endothelial cells: role in fatty acid delivery

Subpopulation Treatment Effect Pattern Plot (STEPP) Methods with R and Stata

Complete Myeloperoxidase Deficiency: Beware the “False-Positive” Dihydrorhodamine Oxidation

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Experimental study on incremental sheet forming of magnesium alloy AZ31 with hot air heating

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

Suchergebnisse filtern